1. Home
  2. WRAP vs ENTX Comparison

WRAP vs ENTX Comparison

Compare WRAP & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WRAP
  • ENTX
  • Stock Information
  • Founded
  • WRAP 2016
  • ENTX 2010
  • Country
  • WRAP United States
  • ENTX Israel
  • Employees
  • WRAP N/A
  • ENTX N/A
  • Industry
  • WRAP Ordnance And Accessories
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WRAP Industrials
  • ENTX Health Care
  • Exchange
  • WRAP Nasdaq
  • ENTX Nasdaq
  • Market Cap
  • WRAP 91.2M
  • ENTX 90.2M
  • IPO Year
  • WRAP N/A
  • ENTX 2018
  • Fundamental
  • Price
  • WRAP $2.13
  • ENTX $2.29
  • Analyst Decision
  • WRAP
  • ENTX Strong Buy
  • Analyst Count
  • WRAP 0
  • ENTX 1
  • Target Price
  • WRAP N/A
  • ENTX $10.00
  • AVG Volume (30 Days)
  • WRAP 142.2K
  • ENTX 94.0K
  • Earning Date
  • WRAP 11-14-2024
  • ENTX 03-07-2025
  • Dividend Yield
  • WRAP N/A
  • ENTX N/A
  • EPS Growth
  • WRAP N/A
  • ENTX N/A
  • EPS
  • WRAP N/A
  • ENTX N/A
  • Revenue
  • WRAP $4,231,000.00
  • ENTX $99,000.00
  • Revenue This Year
  • WRAP N/A
  • ENTX N/A
  • Revenue Next Year
  • WRAP N/A
  • ENTX N/A
  • P/E Ratio
  • WRAP N/A
  • ENTX N/A
  • Revenue Growth
  • WRAP N/A
  • ENTX 607.14
  • 52 Week Low
  • WRAP $1.21
  • ENTX $0.84
  • 52 Week High
  • WRAP $4.33
  • ENTX $3.35
  • Technical
  • Relative Strength Index (RSI)
  • WRAP 57.39
  • ENTX 48.04
  • Support Level
  • WRAP $1.92
  • ENTX $2.21
  • Resistance Level
  • WRAP $2.07
  • ENTX $2.62
  • Average True Range (ATR)
  • WRAP 0.11
  • ENTX 0.20
  • MACD
  • WRAP -0.01
  • ENTX -0.01
  • Stochastic Oscillator
  • WRAP 72.66
  • ENTX 46.77

About WRAP Wrap Technologies Inc.

Wrap Technologies Inc offers public safety technologies and services. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

Share on Social Networks: